Yawen Chen

The ‌UK group fell by $5 bln after ousting Chair Albert Manifold over conduct concerns. It ​adds to a history of ​abrupt exits, including former CEO Bernard Looney. ⁠While the oil major is ​in a better place under CEO Meg ​O’Neill, repeated scandals will cement a governance discount.

At $72 a barrel, Brent crude's level suggests the Gulf crisis ​is over. But the sugar ​rush from clearing stuck cargoes masks ⁠an oil supply deficit. Freight ​rates for shipping through the Strait ​of Hormuz, which have retreated but remain high, give a better sense of ​ongoing risks.

Segro spurned the $130 bln US landlord’s ‌recent offer as too low. The real question is how much Prologis can pay before buying its ​target looks less attractive than building its ​own logistics and data centres. Its recent ⁠deal returns suggest it can raise its ​offer by nearly 10%.

Surprisingly flexible ​demand meant the world’s ⁠top importer ​acted as a ​brake on crude values rising even higher this ​year. As ​oil trades near $100 a barrel ‌again, ⁠the key question is whether Beijing will flip ​and rapidly ​rebuild ⁠stockpiles. There’s reason to ​think it might ​not.

DCC agreed to sell to ‌KKR and Energy Capital Partners for nearly £6 bln. Investors have largely discounted the Irish energy distributor's ​board-backed 2030 profit targets. Without the ​deal, DCC would need to spend years ⁠trying to achieve them through difficult acquisitions.

Kering shares rose 12% ​as it and rivals like LVMH flagged how wealthier-feeling ‌Americans are driving growth amid subdued Chinese demand. Yet if luxury increasingly depends on gains in a narrow slice of the US stock ​market, it looks more exposed to a long-feared correction.

New CEO Dave Lewis announced ​a $1 bln savings programme in a bid to restore ‌growth at the $51 bln tequila-to-Guinness seller. Yet a turnaround in the critical US market looks uncertain, and debt remains high. Diageo’s lowly valuation is unlikely to ​recover soon.

Accurate molecular subtyping of breast cancer is essential for treatment planning, yet computational methods face challenges from class imbalance and variable-quality histopathology features.

The Israeli group’s sales and profits are up, with an even stronger ​second half on the ​horizon. Yet its shares trade at $27, ⁠below Hapag-Lloyd's $35 bid. Government resistance ​imperils the $4.2 bln deal, but ​freight-rate gains could leave investors better off than feared.

Crude is ‌trading at $92 a barrel, but de-escalation, reserve releases and softer demand could send it ​lower. Still, buffers are thinning just ​as Treasury Secretary Scott Bessent threatens 'the ⁠greatest financial offensive ever'. If Hormuz ​stays impaired, prices will stay high.